It was around 2018 when Kevin Lawson, Lakshmanan Suresh and Long Shen were approached by Empire Genomics, a Western New York company that was looking to spin off the laboratory testing part of its business.Â
“They said they’re going to shut down the lab unless somebody comes in to manage it or help out,” recalled Lawson.
The three partners, all Western New Yorkers and experienced in laboratory medicine, didn’t want to see that happen.
And so KSL Diagnostics was born, launched by diving into a business that another company was ready to shut down.
KSL Diagnostics has grown steadily since then: A company that had eight employees after taking over Empire Genomics’ clinical lab more than five years ago now employs more than 100 people worldwide, including about 60 in Western New York.
The company, headquartered near Buffalo Niagara International Airport in Cheektowaga, is at least partially fueled by an underlying desire to preserve and bolster the region’s clinical laboratory medicine industry.Â
The specialized laboratory company provides testing services for infectious diseases, hematology/oncology, molecular pathology, immunogenetics, dermatology, rheumatology, gastroenterology and newborn screening. The company also develops new technologies and novel tests, with more than 500 tests currently listed on KSL’s test menu online.
A UB lab will share a $20 million infusion to identify more Covid-19 variants as part of a…
Read the full article here